What is the market doing?
What the tape says about ASND
Ascendis Pharma A/S is +32% over the past year while the S&P 500 is +23%: 9.0 points ahead of the market.
+32%
1-year return · S&P 500 +23%
- vs 200-day average
- +10%
vs 200-day average · a clear uptrend
- RSI (14)
- 51
RSI (14) · neutral
- Below its 52-week high
- −7.6%
Below its 52-week high
Details›
- Last close2026-08-26
- $250.34
- 1 monthS&P 500 +3.7%
- −0.84%
- 1 yearS&P 500 +23%
- +32%
- 5 yearsS&P 500 +87%
- +108%
- vs 50-day average$242.61
- +3.2%
- 52-week high
- $270.80
- 52-week low
- $189.74
- Annualised volatility
- 42%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$4.4M
| Year | Return |
|---|---|
| 2026 (year to date) | +17% |
| 2025 | +55% |
| 2024 | +9.3% |
| 2023 | +3.1% |
| 2022 | −9.2% |
| 2021 | −19% |
| 2020 | +20% |
| 2019 | +122% |
| 2018 | +56% |
| 2017 | +98% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +3.0% |
| Feb | 10 | 7 of 10 | +8.0% |
| Mar | 10 | 4 of 10 | +3.2% |
| Apr | 10 | 5 of 10 | −2.6% |
| May | 10 | 4 of 10 | +1.5% |
| Jun | 10 | 7 of 10 | +3.7% |
| Jul | 11 | 6 of 11 | −1.4% |
| Aug | 11 | 8 of 11 | +8.8% |
| Sep | 10 | 7 of 10 | +5.1% |
| Oct | 10 | 4 of 10 | −1.2% |
| Nov | 10 | 9 of 10 | +5.3% |
| Dec | 10 | 5 of 10 | +4.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
Ranks #59 of 145 by Smart Score